| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/27/2010 | EP2147683A1 Construct and method for the internalization of cargo molecules into a cell |
| 01/27/2010 | EP2147682A2 Vaccination with immuno-isolated cells producing an immunomodulator |
| 01/27/2010 | EP2147677A1 Eradicating agent for helicobacter pylori |
| 01/27/2010 | EP2147672A1 Cytotoxic t cell activator comprising ep4 agonist |
| 01/27/2010 | EP2147091A2 Broad-spectrum antibacterial and antifungal activity of lactobacillus johnsonii d115 |
| 01/27/2010 | EP2146991A2 Triazolopyridine carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 01/27/2010 | EP2146988A1 New 4,8-diphenyl-polyazanaphthalene derivatives |
| 01/27/2010 | EP2146984A1 Hepatitis c virus inhibitors |
| 01/27/2010 | EP2146967A2 Tetrahydroindole and tetrahydroindazole derivatives |
| 01/27/2010 | EP1438298B1 Piperazine derivatives with ccr1 receptor antagonist activity |
| 01/27/2010 | EP1362106B1 Streptococcus pyogenes polypeptides and corresponding dna fragments |
| 01/27/2010 | EP1343485B1 Drug delivery system comprising a lipid-based nitric oxide donor |
| 01/27/2010 | EP1303503B1 Aniline derivatives |
| 01/27/2010 | EP1206563B1 Genetically altered dendritic cells transduced with adeno-associated virus (aav), methods of producing said cells and uses thereof |
| 01/27/2010 | CN101633907A Amplification culture method for antigen specific cytotoxic t lymphocytes |
| 01/27/2010 | CN101633692A Methods for making apo-2 ligand using divalent metal ions |
| 01/27/2010 | CN101633650A Novel compounds, pharmaceutical compositions containing same, and methods of use for same |
| 01/27/2010 | CN101633636A Peptidomimetic protease inhibitors |
| 01/27/2010 | CN101632669A Method of using diketopiperazines and composition containing them |
| 01/27/2010 | CN101632627A Solution for ungual and peri-ungual application |
| 01/27/2010 | CN100584945C Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression |
| 01/27/2010 | CN100584860C A plurality of reconstructing antibiotic peptide and preparation method and application thereof |
| 01/27/2010 | CN100584859C Process for the preparation of echinocandin derivatives |
| 01/27/2010 | CN100584841C Andrographolide derivatives and application of the same in pharmacy |
| 01/27/2010 | CN100584837C Hydroxy stilbene kind compound and its preparation method and application |
| 01/27/2010 | CN100584828C New 5-hydroxy indole-3- carboxylic esters derivative |
| 01/27/2010 | CN100584380C Production of gamma immune protein capsules |
| 01/27/2010 | CN100584378C Use of mycobacterium antigen MPB64 in preparing product for locally detecting active tuberculosis |
| 01/27/2010 | CN100584355C Supercritical carbon dioxide method for extracting high purity rhubarb free anthraquinones |
| 01/27/2010 | CN100584354C A medicine for treating zoster sequela neuralgia |
| 01/27/2010 | CN100584350C Medicine for treating myocarditis |
| 01/27/2010 | CN100584345C Distillage of Ardisia chinensis Benth of possessing function of antivirus, extraction method and application |
| 01/26/2010 | US7653495 Comprises series of steps including identifying cavity proximal to functional critical site, determining physical parameters of cavity, identifying functional groups which can be accommodated by cavity, testing compounds comprising such functional groups in an in vitro assay to determine which are active |
| 01/26/2010 | US7652144 Compounds as PDE IV and TNF inhibitors |
| 01/26/2010 | US7652054 Gastrointestinal disorders; cardiovascular disorders; dyspepsia;anticancer agents; antiulcer agents |
| 01/26/2010 | US7652050 Prevention reproduction of fish viruses |
| 01/26/2010 | US7652045 Activator of peroxisome proliferator-activated receptor δ |
| 01/26/2010 | US7652025 Remedies for sepsis |
| 01/26/2010 | US7652004 7H-indolo[2,1-a][2]benzazepine-10-carboxylic acid, 13-cyclohexyl-3-methoxy-6-[3-(4-morpholinylcarbonyl)-2-pyridinyl]-, 1,1-dimethylethyl ester; 7H-indolo[2,1-a][2]benzazepine-10-carboxylic acid, 13-cyclohexyl-3-methoxy-6-[2-(4-morpholinylcarbonyl)phenyl]-, 1,1-dimethylethyl ester |
| 01/26/2010 | US7651999 2′, 5′-oligoadenylate analogs |
| 01/26/2010 | US7651997 Deoxo-proline-containing tamandarin and didemnin analogs, dehydro-proline-containing tamandarin and didemnin analogs, and methods of making and using them |
| 01/26/2010 | US7651857 Inhibiting antigen presentation, comprising the step of supplying to an antigen-presenting cell, such as a dendritic cell, or precursor cell, a modulator, preferably an enhancer, of Toll-related receptor signalling |
| 01/26/2010 | US7651842 Imunogenic complex comprising ribosomes |
| 01/26/2010 | US7651698 Prolonged release bioadhesive therapeutic systems |
| 01/26/2010 | CA2493534C Pegylated t20 polypeptide |
| 01/26/2010 | CA2481012C Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
| 01/26/2010 | CA2469380C Heteroaryl-substituted aminocyclohexane derivatives |
| 01/26/2010 | CA2456606C 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 01/26/2010 | CA2447099C Delivery of compounds for the treatment of migraine through an inhalation route |
| 01/26/2010 | CA2434731C Modular infusion device and method |
| 01/26/2010 | CA2421588C Tnf receptor-like molecules and uses thereof |
| 01/26/2010 | CA2383105C Intranasal influenza virus vaccine |
| 01/26/2010 | CA2349629C Methods for the production of tcr gamma delta t cells |
| 01/26/2010 | CA2336791C Preparation and use of sulfur-containing phosphonoformate derivatives and analogs |
| 01/26/2010 | CA2328803C Anti-procalcitonin antibodies and the preparation and use thereof |
| 01/26/2010 | CA2303934C Tetrazole-containing rapamycin analogs with shortened half-lives |
| 01/26/2010 | CA2301499C T-cell membrane protein (tirc7), peptides and antibodies derived therefrom and uses thereof |
| 01/26/2010 | CA2300407C 4-cyano-4-deformylsordarin derivatives |
| 01/26/2010 | CA2230086C Method to improve the biological and antiviral activity of protease inhibitors |
| 01/21/2010 | WO2010009380A2 Methods for treating immune-mediated dengue fever infections and antibody-dependent enhancement of dengue fever infections, including dengue hemorrhagic fever and dengue shock syndrome |
| 01/21/2010 | WO2010009277A2 Immunogenic amphipathic peptide compositions |
| 01/21/2010 | WO2010009183A1 Pyridone and pyridazone analogues as gpr119 modulators |
| 01/21/2010 | WO2010009068A2 Cyclohexenyl modulators of chemokine receptor activity |
| 01/21/2010 | WO2010009047A1 Pyridone derivatives as non-nucleoside reverse transcriptase inhibitors |
| 01/21/2010 | WO2010009014A2 Antibiotic drug |
| 01/21/2010 | WO2010008493A2 Processes for preparing high purity aza cyclohexapeptides |
| 01/21/2010 | WO2010008318A1 Antiviral agent |
| 01/21/2010 | WO2010007972A1 Novel indole derivative having carbamoyl group, ureide group and substituted oxy group |
| 01/21/2010 | WO2010007800A1 Novel uracil compound having amide structure and salt thereof |
| 01/21/2010 | WO2010007381A1 Antibacterial combination therapy for the treatment of gram positive bacterial infections |
| 01/21/2010 | WO2010006704A1 Oxazolopyrimidines as edg-1 receptor agonists |
| 01/21/2010 | WO2010006697A2 Powders for reconstitution |
| 01/21/2010 | WO2010006607A1 Vaccines comprising tb10.4 |
| 01/21/2010 | WO2010006537A1 A pharmaceutical composition for treatment of livestock’s foot and mouth disease |
| 01/21/2010 | WO2010006508A1 INTEGRIN PEPTIDE, ANTI-CD 18 βA ANTIBODY FOR TREATMENT OF ENDOTOXIN-MEDIATED PRO-INFLAMMATORY RESPONSES AND THE USE |
| 01/21/2010 | WO2010006452A1 New influenza virus immunizing epitope |
| 01/21/2010 | WO2010006447A1 Chimeric respiratory syncytial virus polypeptide antigens |
| 01/21/2010 | WO2009146147A3 Target-responsive hydrogels |
| 01/21/2010 | WO2009139004A3 Tat dna sequences, gene constructs, vaccine and processes thereof |
| 01/21/2010 | WO2009137133A3 5-substituted-2-imino-thiazolidinone compounds and their use as inhibitors of bacterial infection |
| 01/21/2010 | WO2009137130A3 Antibacterial fluoroquinolone analogs |
| 01/21/2010 | WO2009126293A3 Potent chimeric nrti-nnrti bifunctional inhibitors of hiv-1 reverse transcriptase |
| 01/21/2010 | WO2009124184A3 Azabenzanthrones for the treatment of viral infections, cancer or restenosis |
| 01/21/2010 | WO2009115927A3 Nucleotide analogues with quaternary carbon stereogenic centers and methods of use |
| 01/21/2010 | WO2009115652A3 Bitherapy and tritherapy used for treating an hiv-positive patient |
| 01/21/2010 | WO2009103319A3 Ezrin, serpin b5, peroxiredoxin-2 and heat shock protein beta-1 as autoantigens for treating or detecting streptococcal diseases |
| 01/21/2010 | WO2008156092A8 Azolylmethylidenehydrazine derivative and use thereof |
| 01/21/2010 | WO2008134450A3 Broad-spectrum antibacterial and antifungal activity of lactobacillus johnsonii d115 |
| 01/21/2010 | US20100016956 Triazole compounds and methods of making and using the same |
| 01/21/2010 | US20100016955 Triazole compounds and methods of making and using the same |
| 01/21/2010 | US20100016783 Non-invasive systems and methods for in-situ photobiomodulation |
| 01/21/2010 | US20100016560 Monoclonal antibody that binds to an epitope of the lipopolysaccharide (LPS) inner core of Neisseria meningitidis for prevention and treatment of neisserial infections |
| 01/21/2010 | US20100016557 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 01/21/2010 | US20100016424 Production and use of derivatized homoserine lactones |
| 01/21/2010 | US20100016419 Antibacterial composition |
| 01/21/2010 | US20100016415 Proteins Expressed by Mycobacterium Tuberculosis and not by BCG and their use as Diagnostic Reagents and Vaccines |
| 01/21/2010 | US20100016409 Rna Nanoparticles and Nanotubes |
| 01/21/2010 | US20100016367 Bis-pyrinidium compounds |
| 01/21/2010 | US20100016361 Aryl carboxylic acid cyclohexyl amide derivatives |
| 01/21/2010 | US20100016359 Methods for controlling sr protein phosphorylation, and antiviral agents whose active ingredients comprise agents that control sr protein activity |